ArticleMaterials today. Bio2026

Brain-targeting nanoplatform repurposing silymarin for enhanced GBM immunotherapy via synergistic mitochondrial suppression.

Jiaqi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.